---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-018985"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:33:39.699452+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision details pro forma dilution to new investors at $1.25/share in ATM offering

## Summary
- Historical net tangible book value as of Mar 31, 2025: $(15.8)M or $(1.71)/share; after offering: $(14.6)M or $(0.95)/share.
- ATM offering assumes 4,333,333 shares at $0.30/share (May 14 close), net proceeds $1.2M; dilution to new investors $(1.25)/share.
- Pro forma adjustments include 1,748,666 shares issued in April 2025; total outstanding after offering ~15.4M shares.
- As of Mar 31, 2025, 17.4M warrants (weighted avg exercise $2.20) and 2.2M options outstanding represent additional dilution.

## SEC filing metadata
- accession: 0001437749-25-018985
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774925018985/0001437749-25-018985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774925018985/vtak20250528_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-018985
- JSON: https://secwatch.observer/filing/0001437749-25-018985.json
- Plain text: https://secwatch.observer/filing/0001437749-25-018985.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.